TANDEM DIABETES CARE INC Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Amendment No. 1 to Distributor Agreement, dated May 10, 2024, by Unomedical a/s and the Company (Filed With SEC on August 1, 2024)
- Employee Offer Letter, dated (Filed With SEC on August 1, 2024)
- Amended and Restated Commercialization Agreement, dated May 22, 2024, by and between the Company and DexCom, Inc (Filed With SEC on August 1, 2024)
- Form of Confirmation for Capped Call Transactions (Filed With SEC on March 11, 2024)
- Employee Offer Letter, dated October 31, 2023, by and between Tandem Diabetes Care, Inc. and Mark Novara (Filed With SEC on February 21, 2024)
- Commercialization Agreement, dated January 14, 2022, by and between Tandem Diabetes Care, Inc. and Unomedical A/S (Filed With SEC on February 22, 2022)
- Commercialization Agreement, dated November 20, 2020, by and between Tandem Diabetes Care, Inc. and DexCom, Inc (Filed With SEC on February 24, 2021)
- Second Amendment to (Filed With SEC on November 5, 2020)
- OMNIBUS AMENDMENT AGREEMENT NO. 2 (Filed With SEC on April 30, 2015)
- CONSENT AND AMENDMENT AGREEMENT (Filed With SEC on July 31, 2014)
- CONFIDENTIAL INTELLECTUAL PROPERTY AGREEMENT (Filed With SEC on October 24, 2013)
- SECTION 1. EXERCISE. (Filed With SEC on October 7, 2013)
